CIT-Logo-White Created with Sketch.
News Issue Archive Device Guide Calendar Subscribe Advertising

MENU

Device Guides
Trial Guide
Centers

CTO DES Hypertension Imaging Modalities PCI Pharmacology Radial Regulatory Structural Disease Valvular Interventions

News Current Issue Archive Device Guide Calendar Subscribe Advertising About Contact Privacy Submissions
CTO DES Hypertension Imaging Modalities PCI Pharmacology Radial Regulatory Structural Disease Valvular Interventions

Advertisement

Advertisement

Search Results

Show Filters

close Created with Sketch.

Refine by Content Type

close Created with Sketch.

Refine by Year

close Created with Sketch.

Advertisement

Sort By:

Relevance Date

Choose Sites to Search:

CIToday CIToday + EVToday

cit | Article | March/April 2025

Comprehensive Multimodality Imaging Assessment of Aortic Regurgitation

A discussion of echocardiographic assessment combined with cardiac MR and CT for comprehensive aortic regurgitation evaluation.

By Takahiro Nishihara, MD; Go Hashimoto, MD; Stephanie Schmidt, RDCS; Paul Sorajja, MD; Vinayak Bapat, MD; Nadira Hamid, MD; Maurice Enriquez-Sarano, MD; and João L. Cavalcante, MD

cit | News | March 22, 2023

Ancora Heart’s AccuCinch System Evaluated in Analysis of HFrEF Patients

March 22, 2023—Ancora Heart, Inc., which is developing a completely transcatheter device-based therapy to address heart failure (HF), announced that patients treated with the company’s investigational AccuCinch ventricular restoration system demonstrated improvement in HF patient outcomes and beneficial changes in the structure of the heart.

cit | News | July 31, 2026

VDyne Commences TriNova TTVR System’s TRIVITA US Pivotal Study

July 31, 2026—VDyne Inc. announced that the first patient has been enrolled in the TRIVITA United States investigational device exemption pivotal study of the company’s TriNova transcatheter tricuspid valve replacement (TTVR) system for the treatment for tricuspid regurgitation (TR).

cit | News | June 23, 2025

CORCINCH-HF Pivotal Trial of Ancora Heart’s AccuCinch Reaches Enrollment Milestone

June 23, 2025—Ancora Heart, Inc. announced that it has reached the first enrollment milestone of 250 patients in the prospective, randomized, open-label, multicenter, international CORCINCH-HF pivotal trial of the company’s AccuCinch transcatheter left ventricular restoration system.

Advertisement

Advertisement


1

Advertisement

Advertisement

CTO DES Hypertension Imaging Modalities PCI Pharmacology Radial Regulatory Structural Disease Valvular Interventions
Centers

Coding CTO DES Hypertension Imaging Modalities PCI Pharmacology Radial Regulatory Structural Disease Valvular Interventions Pulmonary Embolism

News• Current Issue• Archive• Device Guides• Advertising• About Calendar• Contact• Privacy• Submissions• Subscriptions


Cardiac Interventions Today (ISSN 2572-5955 print and ISSN 2572-5963 online) is a publication dedicated to providing coverage of the latest developments in technology, techniques, clinical studies, and regulatory and reimbursement issues in the field of coronary and cardiac interventions.



magazine Created with Sketch.

Free Print Subscriptions

Fill 1 Created with Sketch.

Email Newsletter



twitter-icon LinkedIn Created with Sketch. BlueSky-Circle
Endovascular Today
CIT-Logo-Color Created with Sketch.
bmc-secondary-mark-color copy Created with Sketch.

© 2026 Bryn Mawr Communications II, LLC.  
All Rights Reserved   •   Privacy Policy

one-trust-button